INVESTIGACIÓN CURRICULAR
Pfizer (United States)
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Pfizer (United States) (2)
2006
-
Exon 3-deleted/full-length growth hormone receptor polymorphism genotype frequencies in Spanish short small-for-gestational-age (SGA) children and adolescents (n = 247) and in an adult control population (n = 289) show increased fl/fl in short SGA
Journal of Clinical Endocrinology and Metabolism, Vol. 91, Núm. 12, pp. 5038-5043
-
The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 μg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: Results from a two-year controlled prospective study in 170 Spanish patients
Journal of Clinical Endocrinology and Metabolism, Vol. 91, Núm. 9, pp. 3281-3286